Skip to main content
Top
Gepubliceerd in: Quality of Life Research 6/2018

07-03-2018

Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health

Auteurs: Katelynn Crick, Fatima Al Sayah, Arto Ohinmaa, Jeffrey A. Johnson

Gepubliceerd in: Quality of Life Research | Uitgave 6/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Background

Anxiety and depression disorders are associated with significantly lower health-related quality of life (HRQL). The EQ-5D is a commonly used generic measure of HRQL; it captures mental health through a single domain—the anxiety/depression dimension. Evidence on the responsiveness of this measure in assessing changes in mental health changes is limited.

Objective

To examine the performance of the anxiety/depression dimension (A/D) of the 3- and 5-level (3L and 5L) versions of the EQ-5D in assessing changes in mental health.

Methods

Data from two patient populations were used: 495 adults post-discharge from general internal medicine ward (EQ-5D-3L), and 225 type 2 diabetes patients who screened positive for depressive symptoms (EQ-5D-5L). Anchor-based approach along with effect sizes (ES) and ROC analysis was used. Anchors included patient health questionnaire 9-items “PHQ9” and generalized anxiety disorder 2-item questionnaire “GAD2” for EQ-5D-3L, and PHQ9 and SF-12 mental composite summary scores (MCS) for EQ-5D-5L. A/D change was quantified as the difference between follow-up and baseline levels.

Results

The A/D dimension of the EQ-5D-3L showed limited responsiveness to changes in depressive symptoms measured by PHQ9 and for anxiety symptoms measured by GAD2, whereby in those who improved or deteriorated in either symptom, more than half of the patients did not have an A/D change. In the ROC analysis, the A/D dimension of the EQ-5D-3L showed weak performance with C-indices ranging from 0.58 to 0.63 and probability of detection of depressive or anxiety symptoms ranging between 20 and 40%, which are all well below acceptable ranges. Similar results were observed for the A/D dimension of the EQ-5D-5L; although the performance was slightly better, it was still below acceptable range. In patients who improved or deteriorated based on the PHQ9 or MCS, around a third had no changes on the A/D dimension. The performance of the A/D dimension of the EQ-5D-5L was also very limited with C-indices ranging between 0.67 and 0.76, and probability of detection between 50 and 67%, slightly better than that of the 3L, yet unsatisfactory.

Conclusions

Although the A/D of both EQ-5D-3L and 5L was limited in capturing changes in mental health in these populations, the 5L was slightly more responsive than the 3L. While the performance was better for depressive than anxiety symptoms, it varied by the direction of change. Further research using other measures of mental health in other populations is warranted.
Literatuur
1.
go back to reference EuroQol Group. (1990). EuroQol: A new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef EuroQol Group. (1990). EuroQol: A new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
2.
go back to reference Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.CrossRefPubMedPubMedCentral Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.CrossRefPubMedPubMedCentral
3.
go back to reference Agborsangaya, C. B., Lahtinen, M., Cooke, T., & Johnson, J. A. (2014). Comparing the EQ-5D 3L and 5L: Measurement properties and association with chronic conditions and multimorbidity in the general population. Health & Quality of Life Outcomes, 12, 74.CrossRef Agborsangaya, C. B., Lahtinen, M., Cooke, T., & Johnson, J. A. (2014). Comparing the EQ-5D 3L and 5L: Measurement properties and association with chronic conditions and multimorbidity in the general population. Health & Quality of Life Outcomes, 12, 74.CrossRef
4.
go back to reference Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717–1727.CrossRefPubMed Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717–1727.CrossRefPubMed
5.
go back to reference Pattanaphesaj, J., & Thavorncharoensap, M. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health & Quality of Life Outcomes, 13, 14.CrossRef Pattanaphesaj, J., & Thavorncharoensap, M. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health & Quality of Life Outcomes, 13, 14.CrossRef
6.
go back to reference Scalone, L., Ciampichini, R., Fagiuoli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Quality of Life Research, 22(7), 1707–1716.CrossRefPubMed Scalone, L., Ciampichini, R., Fagiuoli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Quality of Life Research, 22(7), 1707–1716.CrossRefPubMed
7.
go back to reference Hybels, C. F., & Blazer, D. G. (2003). Epidemiology of late-life mental disorders. Clinics in Geriatric Medicine, 19(4), 663–696.CrossRefPubMed Hybels, C. F., & Blazer, D. G. (2003). Epidemiology of late-life mental disorders. Clinics in Geriatric Medicine, 19(4), 663–696.CrossRefPubMed
8.
go back to reference Pyne, J. M., Patterson, T. L., Kaplan, R. M., & Ho, S. (1997). Preliminary longitudinal assessment of quality of life in patients with major depression. Psychopharmacology Bulletin, 33(1), 23.PubMed Pyne, J. M., Patterson, T. L., Kaplan, R. M., & Ho, S. (1997). Preliminary longitudinal assessment of quality of life in patients with major depression. Psychopharmacology Bulletin, 33(1), 23.PubMed
9.
go back to reference Revicki, D. A., & Wood, M. (1998). Patient-assigned health state utilities for depression-related outcomes: Differences by depression severity and antidepressant medications. Journal of Affective Disorders, 48(1), 25–36.CrossRefPubMed Revicki, D. A., & Wood, M. (1998). Patient-assigned health state utilities for depression-related outcomes: Differences by depression severity and antidepressant medications. Journal of Affective Disorders, 48(1), 25–36.CrossRefPubMed
10.
go back to reference Sapin, C., Fantino, B., Nowicki, M.-L., & Kind, P. (2004). Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health and Quality of Life Outcomes, 2(1), 1.CrossRef Sapin, C., Fantino, B., Nowicki, M.-L., & Kind, P. (2004). Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health and Quality of Life Outcomes, 2(1), 1.CrossRef
11.
go back to reference Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, 22PubMed Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, 22PubMed
12.
go back to reference Stein, M. B., Roy-Byrne, P. P., Craske, M. G., Bystritsky, A., Sullivan, G., Pyne, J. M., et al. (2005). Functional impact and health utility of anxiety disorders in primary care outpatients. Medical Care, 43(12), 1164–1170.CrossRefPubMed Stein, M. B., Roy-Byrne, P. P., Craske, M. G., Bystritsky, A., Sullivan, G., Pyne, J. M., et al. (2005). Functional impact and health utility of anxiety disorders in primary care outpatients. Medical Care, 43(12), 1164–1170.CrossRefPubMed
13.
go back to reference Strine, T. W., Chapman, D. P., Kobau, R., & Balluz, L. (2005). Associations of self-reported anxiety symptoms with health-related quality of life and health behaviors. Social Psychiatry and Psychiatric Epidemiology, 40(6), 432–438.CrossRefPubMed Strine, T. W., Chapman, D. P., Kobau, R., & Balluz, L. (2005). Associations of self-reported anxiety symptoms with health-related quality of life and health behaviors. Social Psychiatry and Psychiatric Epidemiology, 40(6), 432–438.CrossRefPubMed
14.
go back to reference Struttmann, T., Fabro, M., Romieu, G., de Roquefeuil, G., Touchon, J., Dandekar, T., et al. (1999). Quality-of-life assessment in the old using the WHOQOL 100: Differences between patients with senile dementia and patients with cancer. International Psychogeriatrics, 11(3), 273–279.CrossRefPubMed Struttmann, T., Fabro, M., Romieu, G., de Roquefeuil, G., Touchon, J., Dandekar, T., et al. (1999). Quality-of-life assessment in the old using the WHOQOL 100: Differences between patients with senile dementia and patients with cancer. International Psychogeriatrics, 11(3), 273–279.CrossRefPubMed
15.
go back to reference Patrick, D. L., & Deyo, R. A. (1989). Generic and disease-specific measures in assessing health status and quality of life. Medical Care, 27(3 Suppl), S217–S232.CrossRefPubMed Patrick, D. L., & Deyo, R. A. (1989). Generic and disease-specific measures in assessing health status and quality of life. Medical Care, 27(3 Suppl), S217–S232.CrossRefPubMed
17.
go back to reference Revicki, D. A., Cella, D., Hays, R. D., Sloan, J. A., Lenderking, W. R., & Aaronson, N. K. (2006). Responsiveness and minimal important differences for patient reported outcomes. Health and Quality of Life Outcomes, 4(1), 1–5.CrossRef Revicki, D. A., Cella, D., Hays, R. D., Sloan, J. A., Lenderking, W. R., & Aaronson, N. K. (2006). Responsiveness and minimal important differences for patient reported outcomes. Health and Quality of Life Outcomes, 4(1), 1–5.CrossRef
18.
go back to reference Revicki, D. A., Osoba, D., Fairclough, D., Barofsky, I., Berzon, R., Leidy, N. K., et al. (2000). Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Quality of Life Research, 9, 887.CrossRefPubMed Revicki, D. A., Osoba, D., Fairclough, D., Barofsky, I., Berzon, R., Leidy, N. K., et al. (2000). Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Quality of Life Research, 9, 887.CrossRefPubMed
19.
go back to reference Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61(2), 102–109.CrossRefPubMed Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61(2), 102–109.CrossRefPubMed
20.
go back to reference Kahlon, S., Pederson, J., Majumdar, S. R., Belga, S., Lau, D., Fradette, M., et al. (2015). Association between frailty and 30-day outcomes after discharge from hospital. CMAJ: Canadian Medical Association Journal, 187(11), 799–804.CrossRefPubMedPubMedCentral Kahlon, S., Pederson, J., Majumdar, S. R., Belga, S., Lau, D., Fradette, M., et al. (2015). Association between frailty and 30-day outcomes after discharge from hospital. CMAJ: Canadian Medical Association Journal, 187(11), 799–804.CrossRefPubMedPubMedCentral
21.
go back to reference Johnson, J. A., Al Sayah, F., Wozniak, L., Rees, S., Soprovich, A., Qiu, W., et al. (2014). Collaborative care versus screening and follow-up for patients with diabetes and depressive symptoms: Results of a primary care-based comparative effectiveness trial. Diabetes Care, 37(12), 3220–3226.CrossRefPubMed Johnson, J. A., Al Sayah, F., Wozniak, L., Rees, S., Soprovich, A., Qiu, W., et al. (2014). Collaborative care versus screening and follow-up for patients with diabetes and depressive symptoms: Results of a primary care-based comparative effectiveness trial. Diabetes Care, 37(12), 3220–3226.CrossRefPubMed
22.
go back to reference Rabin, R., & Charro Fd (2001). EQ-SD: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.CrossRefPubMed Rabin, R., & Charro Fd (2001). EQ-SD: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.CrossRefPubMed
23.
go back to reference Löwe, B., Unützer, J., Callahan, C. M., Perkins, A. J., & Kroenke, K. (2004). Monitoring depression treatment outcomes with the patient health questionnaire-9. Medical Care, 42(12), 1194–2201.CrossRefPubMed Löwe, B., Unützer, J., Callahan, C. M., Perkins, A. J., & Kroenke, K. (2004). Monitoring depression treatment outcomes with the patient health questionnaire-9. Medical Care, 42(12), 1194–2201.CrossRefPubMed
24.
go back to reference Arroll, B., Goodyear-Smith, F., Crengle, S., Gunn, J., Kerse, N., Fishman, T., et al. (2010). Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. The Annals of Family Medicine, 8(4), 348–353.CrossRefPubMed Arroll, B., Goodyear-Smith, F., Crengle, S., Gunn, J., Kerse, N., Fishman, T., et al. (2010). Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. The Annals of Family Medicine, 8(4), 348–353.CrossRefPubMed
25.
go back to reference Kroenke, K., Spitzer, R. L., Williams, J. B., & Löwe, B. (2010). The patient health questionnaire somatic, anxiety, and depressive symptom scales: A systematic review. General Hospital Psychiatry, 32(4), 345–359.CrossRefPubMed Kroenke, K., Spitzer, R. L., Williams, J. B., & Löwe, B. (2010). The patient health questionnaire somatic, anxiety, and depressive symptom scales: A systematic review. General Hospital Psychiatry, 32(4), 345–359.CrossRefPubMed
26.
go back to reference Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592.PubMed Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592.PubMed
27.
go back to reference Skapinakis, P. (2007). The 2-item generalized anxiety disorder scale had high sensitivity and specificity for detecting GAD in primary care. Evidence Based Medicine, 12(5), 149.CrossRefPubMed Skapinakis, P. (2007). The 2-item generalized anxiety disorder scale had high sensitivity and specificity for detecting GAD in primary care. Evidence Based Medicine, 12(5), 149.CrossRefPubMed
28.
go back to reference Fleishman, J. A., Selim, A. J., Kazis, L. E.. Deriving (2010). SF-12v2 physical and mental health summary scores: A comparison of different scoring algorithms. Quality of Life Research, 19(2), 231–241.CrossRefPubMed Fleishman, J. A., Selim, A. J., Kazis, L. E.. Deriving (2010). SF-12v2 physical and mental health summary scores: A comparison of different scoring algorithms. Quality of Life Research, 19(2), 231–241.CrossRefPubMed
29.
go back to reference Ware, J. E. K. M., & Keller, S. D. (1995). SF-12: How to score the SF-12 physical and mental health summary scales. Boston: The Health Institute, New England Medical Center. Ware, J. E. K. M., & Keller, S. D. (1995). SF-12: How to score the SF-12 physical and mental health summary scales. Boston: The Health Institute, New England Medical Center.
30.
go back to reference Rosenthal, J. A. (1996). Qualitative descriptors of strength of association and effect size. Journal of Social Service Research, 21(4), 37–59.CrossRef Rosenthal, J. A. (1996). Qualitative descriptors of strength of association and effect size. Journal of Social Service Research, 21(4), 37–59.CrossRef
31.
go back to reference Bell, M. L., & Fairclough, D. L. (2014). Practical and statistical issues in missing data for longitudinal patient-reported outcomes. Statistical Methods in Medical Research, 23(5), 440–459.CrossRefPubMed Bell, M. L., & Fairclough, D. L. (2014). Practical and statistical issues in missing data for longitudinal patient-reported outcomes. Statistical Methods in Medical Research, 23(5), 440–459.CrossRefPubMed
32.
go back to reference Lowe, B., Unutzer, J., Callahan, C. M., Perkins, A. J., & Kroenke, K. (2004). Monitoring depression treatment outcomes with the patient health questionnaire-9. Medical Care, 42(12), 1194–1201.CrossRefPubMed Lowe, B., Unutzer, J., Callahan, C. M., Perkins, A. J., & Kroenke, K. (2004). Monitoring depression treatment outcomes with the patient health questionnaire-9. Medical Care, 42(12), 1194–1201.CrossRefPubMed
33.
go back to reference Carter, J. V., Pan, J., Rai, S. N., & Galandiuk, S. (2016). ROC-ing along: Evaluation and interpretation of receiver operating characteristic curves. Surgery, 159(6), 1638–1645.CrossRefPubMed Carter, J. V., Pan, J., Rai, S. N., & Galandiuk, S. (2016). ROC-ing along: Evaluation and interpretation of receiver operating characteristic curves. Surgery, 159(6), 1638–1645.CrossRefPubMed
34.
go back to reference Hanley, J. A., & McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143(1), 29–36.CrossRefPubMed Hanley, J. A., & McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143(1), 29–36.CrossRefPubMed
35.
go back to reference Pyne, J. M., Patterson, T. L., Kaplan, R. M., Gillin, J. C., Koch, W. L., & Grant, I. (1997). Assessment of the quality of life of patients with major depression. Psychiatric Services, 33, 23 Pyne, J. M., Patterson, T. L., Kaplan, R. M., Gillin, J. C., Koch, W. L., & Grant, I. (1997). Assessment of the quality of life of patients with major depression. Psychiatric Services, 33, 23
36.
go back to reference Salyers, M. P., Bosworth, H. B., Swanson, J. W., Lamb-Pagone, J., & Osher, F. C. (2000). Reliability and validity of the SF-12 health survey among people with severe mental illness. Medical Care, 38(11), 1141–1150.CrossRefPubMed Salyers, M. P., Bosworth, H. B., Swanson, J. W., Lamb-Pagone, J., & Osher, F. C. (2000). Reliability and validity of the SF-12 health survey among people with severe mental illness. Medical Care, 38(11), 1141–1150.CrossRefPubMed
37.
go back to reference Supina, A. L., Johnson, J. A., Patten, S. B., Williams, J. V., & Maxwell, C. J. (2007). The usefulness of the EQ-5D in differentiating among persons with major depressive episode and anxiety. Quality of Life Research, 16(5), 749–754.CrossRefPubMed Supina, A. L., Johnson, J. A., Patten, S. B., Williams, J. V., & Maxwell, C. J. (2007). The usefulness of the EQ-5D in differentiating among persons with major depressive episode and anxiety. Quality of Life Research, 16(5), 749–754.CrossRefPubMed
38.
go back to reference Traki, L., Rostom, S., Tahiri, L., Bahiri, R., Harzy, T., Abouqal, R., et al. (2014). Responsiveness of the EuroQol EQ-5D and hospital anxiety and depression scale (HADS) in rheumatoid arthritis patients receiving tocilizumab. Clinical Rheumatology, 33(8), 1055–1060.CrossRefPubMed Traki, L., Rostom, S., Tahiri, L., Bahiri, R., Harzy, T., Abouqal, R., et al. (2014). Responsiveness of the EuroQol EQ-5D and hospital anxiety and depression scale (HADS) in rheumatoid arthritis patients receiving tocilizumab. Clinical Rheumatology, 33(8), 1055–1060.CrossRefPubMed
39.
go back to reference Gerhards, S. A. H., Huibers, M. J. H., Theunissen, K. A. T. M., de Graaf, L. E., Widdershoven, G. A. M., & Evers, S. M. A. A. (2011). The responsiveness of quality of life utilities to change in depression: A comparison of instruments (SF-6D, EQ-5D, and DFD). Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 14(5), 732–739.CrossRef Gerhards, S. A. H., Huibers, M. J. H., Theunissen, K. A. T. M., de Graaf, L. E., Widdershoven, G. A. M., & Evers, S. M. A. A. (2011). The responsiveness of quality of life utilities to change in depression: A comparison of instruments (SF-6D, EQ-5D, and DFD). Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 14(5), 732–739.CrossRef
40.
go back to reference Mulhern, B., Mukuria, C., Barkham, M., Knapp, M., Byford, S., Soeteman, D., et al. (2014). Using generic preference-based measures in mental health: Psychometric validity of the EQ-5D and SF-6D. The British Journal of Psychiatry: The Journal of Mental Science, 205(3), 236–243.CrossRef Mulhern, B., Mukuria, C., Barkham, M., Knapp, M., Byford, S., Soeteman, D., et al. (2014). Using generic preference-based measures in mental health: Psychometric validity of the EQ-5D and SF-6D. The British Journal of Psychiatry: The Journal of Mental Science, 205(3), 236–243.CrossRef
41.
go back to reference Whynes, D. K., & Group, T. (2009). Responsiveness of the EQ-5D to HADS-identified anxiety and depression. Journal of Evaluation in Clinical Practice, 15(5), 820–825.CrossRefPubMed Whynes, D. K., & Group, T. (2009). Responsiveness of the EQ-5D to HADS-identified anxiety and depression. Journal of Evaluation in Clinical Practice, 15(5), 820–825.CrossRefPubMed
42.
go back to reference Bhadhuri, A., Jowett, S., Jolly, K., & Al-Janabi, H. (2017). A comparison of the validity and responsiveness of the EQ-5D-5L and SF-6D for measuring health spillovers: A study of the family impact of meningitis. Medical Decision Making: An International Journal of the Society for Medical Decision Making, 37(8), 882–893.CrossRef Bhadhuri, A., Jowett, S., Jolly, K., & Al-Janabi, H. (2017). A comparison of the validity and responsiveness of the EQ-5D-5L and SF-6D for measuring health spillovers: A study of the family impact of meningitis. Medical Decision Making: An International Journal of the Society for Medical Decision Making, 37(8), 882–893.CrossRef
43.
go back to reference Cheung, P. W. H., Wong, C. K. H., Lau, S. T., & Cheung, J. P. Y. (2017). Responsiveness of the EuroQoL 5-dimension (EQ-5D) in adolescent idiopathic scoliosis. European Spine Journal: Official Publication of the European Spine Society, The European Spinal Deformity Society, and The European Section of the Cervical Spine Research Society, 27, 278CrossRef Cheung, P. W. H., Wong, C. K. H., Lau, S. T., & Cheung, J. P. Y. (2017). Responsiveness of the EuroQoL 5-dimension (EQ-5D) in adolescent idiopathic scoliosis. European Spine Journal: Official Publication of the European Spine Society, The European Spinal Deformity Society, and The European Section of the Cervical Spine Research Society, 27, 278CrossRef
44.
go back to reference Nolan, C. M., Longworth, L., Lord, J., Canavan, J. L., Jones, S. E., Kon, S. S. C., et al. (2016). The EQ-5D-5L health status questionnaire in COPD: Validity, responsiveness and minimum important difference. Thorax, 71(6), 493–500.CrossRefPubMedPubMedCentral Nolan, C. M., Longworth, L., Lord, J., Canavan, J. L., Jones, S. E., Kon, S. S. C., et al. (2016). The EQ-5D-5L health status questionnaire in COPD: Validity, responsiveness and minimum important difference. Thorax, 71(6), 493–500.CrossRefPubMedPubMedCentral
46.
go back to reference Johnson, J. A., Lier, D. A., Soprovich, A., Al Sayah, F., Qiu, W., & Majumdar, S. R. (2016). Cost-effectiveness evaluation of collaborative care for diabetes and depression in primary care. American Journal of Preventive Medicine, 51(1), e13–e20.CrossRef Johnson, J. A., Lier, D. A., Soprovich, A., Al Sayah, F., Qiu, W., & Majumdar, S. R. (2016). Cost-effectiveness evaluation of collaborative care for diabetes and depression in primary care. American Journal of Preventive Medicine, 51(1), e13–e20.CrossRef
47.
go back to reference Al Sayah, F JJ, & Ohinmaa, A. (Eds.). (2016). The performance of EQ-5D-5L and VR-12 in assessing mental health. ISOQOL 23rd annual conference (pp. 19–22). Copenhagen: Quality of Life Research. Al Sayah, F JJ, & Ohinmaa, A. (Eds.). (2016). The performance of EQ-5D-5L and VR-12 in assessing mental health. ISOQOL 23rd annual conference (pp. 19–22). Copenhagen: Quality of Life Research.
Metagegevens
Titel
Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health
Auteurs
Katelynn Crick
Fatima Al Sayah
Arto Ohinmaa
Jeffrey A. Johnson
Publicatiedatum
07-03-2018
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 6/2018
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-018-1828-1

Andere artikelen Uitgave 6/2018

Quality of Life Research 6/2018 Naar de uitgave